Kiora Pharmaceuticals Inc...

NASDAQ: KPRX · Real-Time Price · USD
2.90
0.37 (14.62%)
At close: Aug 15, 2025, 12:55 PM

Kiora Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
16.02M n/a n/a n/a
Cost of Revenue
379.51K 4.03M 134.03K 227.27K
Gross Profit
16M -4.03M -134.03K -227.27K
Operating Income
4.51M -12.59M -12.31M -14.24M
Interest Income
1.25M 173.99K 56.89K 1.14K
Pretax Income
5.66M -12.42M -13.7M -13.96M
Net Income
3.59M -12.51M -13.58M -16.39M
Selling & General & Admin
5.54M 4.66M 8.14M 4.96M
Research & Development
7.84M 4.03M 3.45M 5.35M
Other Expenses
-2.25M -130.32K -2.73M n/a
Operating Expenses
11.13M 8.56M 8.86M 10.31M
Interest Expense
21.45K 11.13K 8.6K 6.85K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.49M 12.59M 12.31M 14.24M
Income Tax Expense
2.07M 90.32K -113.01K -192.6K
Shares Outstanding (Basic)
3.87M 538.01K 732.3K 241.1K
Shares Outstanding (Diluted)
4.13M 538.01K 732.3K 241.1K
EPS (Basic)
0.93 -24.25 -18.55 -68
EPS (Diluted)
0.87 -24.25 -18.55 -68
EBITDA
5.75M -12.35M -10.69M -13.73M
EBIT
5.68M -12.41M -10.73M -13.96M
Depreciation & Amortization
65.7K 62.42K 41.61K 227.27K